SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vion (formerly Oncorx) interesting play on Gene Therapy

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim Oravetz who wrote (324)5/3/2005 12:47:51 PM
From: Jim Oravetz  Read Replies (1) of 370
 
Vion Pharma 1Q Losses 7c/Shr Vs 7c
DOW JONES NEWSWIRES
May 3, 2005 8:01 a.m.

Analysts surveyed: 3

First Call EPS estimates can reflect either net income, operating income or funds from operations.

The company's earnings figure is on a diluted basis. First Call assumes earnings estimates from analysts are on a diluted basis.

+++++++++++

This is a weekly ranking by First Call of the highest-rated stocks, based on analyst comments contributed within the past month to First Call's database.

To be included on the list, a company must be rated by at least five analysts.

First Call Consensus Recommendation Scale
1 = Buy
2 = Buy/Hold
3 = Hold
4 = Hold/Sell
5 = Sell

Most Attractive Issues
---- ---------- ------
Latest # Analysts Previous
Consensus Covering Consensus
(HHGP) 1.0 5 1.5
(VDSI) 1.1 7 1.4
(ROP) 1.2 11 1.4
(AIRN) 1.2 6 1.4
(HUG) 1.2 6 1.0
(ORB) 1.2 6 1.3
(RNT) 1.2 6 1.7
(PGI) 1.2 5 1.5
(CHE) 1.2 5 1.3
(DY) 1.2 5 1.3
(MSSR) 1.2 5 1.3
(VION) 1.2 5 1.3

snip....
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext